[ad_1]
BRASÍLIA – The executive secretary of the Ministry of Health, João Gabbardo dos Reis said that, in addition to chloroquine, the most advanced tests of new treatments for covid-19 they are probably using the blood plasma of cured patients. Plasma contains antibodies against the disease and can help anyone who is fighting the disease. He chloroquine It is a medicine used for malaria and other diseases, and is now being used experimentally, especially in critically ill patients with the new coronavirus.
According to the latest ministry bulletin, covid-19 has already infected 17,857 people in the country, killing 941.
– In addition to chloroquine, probably the closest thing to having a result is using plasma from patients who already have antibodies in their bodies. It is evolving very well, people are working on these new therapeutic possibilities, said Gabbardo, who is number two in the portfolio, only below Minister Luiz Henrique Mandetta.
Coronavirus: Everything you need to know about the disease
According to him, in the next few days the results of studies on new treatments should come out. Chloroquine has as one of its greatest enthusiasts President Jair Bolsonaro. The Ministry of Health, on the other hand, calls for caution, since the drug has side effects, and its risks and benefits need to be weighed. So focus on the most serious patients, where the potential benefits outweigh the risks.
A ministerial bulletin released Thursday adopted the same tone of caution. According to the document, azithromycin-associated chloroquine is identified as a promising drug for covid-19, but it takes another two to three weeks to obtain more reliable test results. According to the bulletin, “there is still no solid evidence that this methodology can be extended to the general population, without an analysis of individual and collective risk.”
follow us on twitter: The GLOBO working group disseminates the main news, guidelines and tips for disease prevention
On Tuesday, the Ministry of Health reported that it is following nine studies to obtain new treatments for Covid-19. More than 100 research centers, such as federal universities and hospitals, participate. According to the ministry, 5,000 patients with mild, moderate and severe symptoms participate in the studies.
In addition to chloroquine and hydroxychloroquine, other substances are being tested in combination with the antibiotic azithromycin. These include: Lopinavir and Ritonavir, used against HIV; These same two drugs, along with the substance Interferon beta-1b, are used to treat multiple sclerosis; and Antiviral Remdesivir, for Ebola.
[ad_2]
